top-banner

METHODS AND TECHNOLOGIES

Copy number variation analysis

CNV ANALYSIS

The reliable identification of single nucleotide variants (SNVs) and small insertions and deletions (InDels) with next-generation sequencing (NGS) technologies has been a cornerstone of routine diagnostics. However, conventional short-read sequencing methods face technical limitations when detecting larger genomic regions (>150bp) with gene dosage variations. To address this, molecular genetic diagnostics have traditionally relied on multiplex PCR combined with fragment length analysis (MLPA) for identifying copy number differences in specific target regions. Despite its high sensitivity, MLPA is constrained by its limited availability, with commercial kits covering only a small fraction of the genomic regions that can be analyzed via NGS.

An alternative solution lies in indirectly identifying copy number variations (CNVs) from existing NGS data. Various algorithms, both commercial and open-source, have been developed to detect CNVs and structural variants (SVs) using diverse methodologies (Pirooznia, Goes et al., 2015). The choice of detection method depends on the sequencing approach. Structural changes such as deletions, duplications, and complex rearrangements (e.g., translocations, inversions) create breakpoints in the DNA. To detect these structural changes, it is necessary to detect the breakpoints using whole genome sequencing (WGS) without PCR amplification. However, due to its extensive scope and high costs, WGS remains impractical for many molecular genetic diagnostic applications. Instead, targeted regions of interest (ROIs) are enriched and sequenced using panel sequencing. Read-depth algorithms are particularly effective for such applications. These algorithms normalize enrichment data across a patient cohort by determining the depth of coverage (number of sequenced DNA fragments) at each genomic position and comparing it to a reference dataset.

Leveraging this approach, a CNV analysis pipeline was developed in Martinsried, Germany, enabling the detection of gene dosage differences at the level of individual targets or exons (Becker, Ziegler et al., 2018). To enhance the pipeline’s specificity, it integrates three independent algorithms for CNV detection. This multi-algorithm approach ensures highly accurate identification of heterozygous, hemizygous, and homozygous CNVs within the analysis region (Ziegler, Becker et al., 2018). This methodology provides significant diagnostic advantages, particularly in scenarios where CNV analysis was previously unfeasible or restricted to a limited number of genes (Busse, Ibisler et al., 2018).

WAYS TO PARTNER WITH US

TarCET IVD Kits

CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form

Learn more

Technology Transfer

Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing

Learn more

Genetic Testing Laboratory

Your partner for
all genetic tests

Learn more

Contact Us

Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.

Learn more

BLOG ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact …

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc…

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of …

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access…

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is…

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti…

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati…

Read more

OUR NETWORK